期刊文献+

卵巢癌细胞侵袭转移相关转录因子表达分析 被引量:2

Analysis on the transcriptional factors associated with ovarian cancer invasion and metastasis
暂未订购
导出
摘要 目的:分析并比较卵巢癌细胞中与肿瘤转移、侵袭相关的转录因子。方法:采用细胞划痕及小室跨膜实验比较卵巢癌细胞HO-8910及其高转移株HO-8910PM的转移侵袭能力差异;采用高通量转录因子活性检测芯片(DNA/蛋白结合芯片)分析并比较两种细胞中转录因子的活化情况,明确与肿瘤侵袭、转移相关表达的转录因子;用转录因子酶联免疫活性分析方法验证芯片检测结果。结果:细胞划痕实验及侵袭实验表明HO-8910PM比HO-8910细胞转移侵袭能力强,在345个转录因子中共筛选出与肿瘤侵袭、转移相关的31个表达差异转录因子。HO-8910PM细胞与HO-8910细胞相比,表达上调的有13种,下调的有18种。v-Maf仅表达于HO-8910PM,HLF仅表达于HO-8910。结论:v-Maf、HLF等31种转录因子可能参与了卵巢癌侵袭转移的相关机制。 Objective:To analyze the potential transcriptional factors associated with ovarian cancer invasion and metastasis.Method:Ovarian cancer cells HO-8910 and HO-8910PM were used as a pair of metastasis in vivo cellular model.The cellular invasion and metastasis ability of HO-8910 and HO-8910PM were compared by scarification assay and millicell chamber artificial reconstituted basement membrane invasion assay.Furthermore,345-channel Protein/DNA array was used to analyze the potential transcriptional factors with invasion and metastasis.Results:A total of 345 candidate transcriptional factors,31 transcriptional factors were associated with migration and metastasis.Compared with HO-8910,31 transcriptional factors showed a different activies in HO-8910PM cells,which including 13 up-regulation and 18 down-regulation.Conclusion:DNA-protein microarry is a useful method to screen the potential transcriptional factors associated with ovarian cancer invasion and metastasis.Transcriptional factors such as v-Maf 、HLF may play an important role in ovarian cancer.
出处 《现代妇产科进展》 CSCD 2012年第11期843-847,共5页 Progress in Obstetrics and Gynecology
基金 福建省科技厅重点资助项目(No:2009Y0007)
关键词 转录因子 卵巢癌 转录因子芯片 侵袭 转移 Transcription factors Ovarian cancer Protein/DNA array Invasion Metastasis
  • 相关文献

参考文献11

  • 1Hernandez L, Hsu SC, Davidson B, et al. Activation of NF- kappaB signaling by inhibitor of NF-kappaB kinase beta increases aggressiveness of ovarian cancer [ J ]. Cancer Res,2010 ;70(10) :4005-4014.
  • 2Darnell JE Jr. Transcription factors as targets for cancer therapy [ J 1. Nat Rev Cancer, 2002,2 (10) :740-749.
  • 3周乐,杨筱凤,王艳,张盈涛,耿宜萍,司履生,王一理.蛋白质组学方法鉴定卵巢癌转移相关蛋白[J].中华病理学杂志,2007,36(12):814-818. 被引量:5
  • 4Makiyama K, Hamada J,Takada M, et al. Aberrant expres- sion of HOX genes in human invasive breast carcinoma [ J ]. Oncol Rep, 2005,13 ( 4 ) : 673-679.
  • 5Yang D, Thangaraju M, Greenehch K, et al. Repression of IFN regulatory factor 8 by DNA methylation is a molecular determinant of apoptotic resistance and metastatic pheno- type in metastatic tumor ceils [ J ]. Cancer Res, 2007,67 (7) :3301-3309.
  • 6Mikula M, Gotzmann J, Fischer AN, et al. The proto-oncop- rotein c-Fos negatively regulates hepatocellular tumorigen- esis [ J ]. Oncogene, 2003,22 (43): 6725-6738.
  • 7Katoh Y,Katoh M. Comparative genomics on Vangll and Vangl2 genes[ J]. Int J Oncol,2005,26(5 ) : 1435-1440.
  • 8Davidson B, Zhang Z, Kleinberg L, et al. Gene expression signatures differentiate ovarian/peritoneal serous carcino- ma from diffuse malignant peritoneal mesothelioma [ J ]. Clin Cancer Res,2006,12(20 Pt 1 ) :5944-5950.
  • 9Dhakshinamoorthy S, Sridharan SR, Li L, et al. Protein/ DNA arrays identify nitric oxide-regulated cis-element and trans-factor activities some of which govern neuroblastoma cell viability [ J ]. Nucleic Acids Res, 2007, 35 ( 16 ) : 5439-5451.
  • 10潘奇,王鲁,孙惠川,刘银坤,叶胜龙,汤钊猷.不同转移潜能人肝癌细胞系转录因子活性差异分析[J].中华肝脏病杂志,2006,14(1):37-40. 被引量:21

二级参考文献30

共引文献24

同被引文献18

  • 1栾英姿,李力,黎丹戎,张玮,唐步坚.五种卵巢癌耐药细胞系的建立及其部分耐药相关基因的表达[J].中华妇产科杂志,2004,39(6):403-407. 被引量:21
  • 2张文晶,李红霞,宋磊,张素梅.应用基因芯片技术筛选卵巢癌紫杉醇耐药差异表达基因[J].肿瘤防治研究,2006,33(1):32-35. 被引量:5
  • 3王燕,钟刚,胡俊波,杨帆,杜欣,吴莺,方敏,李红英.HOXA11基因在人良、恶性子宫内膜增生组织中的表达及临床意义[J].实用妇产科杂志,2007,23(3):145-147. 被引量:4
  • 4Mozzetti S, Ferlini C, Concolino P, et al. Class Ⅲ beta-tubu- lin over expression is a prominent mechanism of paelitaxel re- sistance in ovarian cancer patients [ J]. Clin Cancer Res, 2005, 11 (1): 298-305.
  • 5Poveda-Velasco A, Casado Herrciez A, Cervantes-Ruiparez A, et al. Treatment guide-lines in ovarian cancer [J]. Clin Transl Oneol, 2007, 9 (5): 308-316.
  • 6Kamat A A, Kim T J, Landen C N Jr, et al. Metronomic chemotherapy enhances the efficacy of antivaseular therapy in o- varian cancer [J]. Cancer Res, 2007, 67 (1), 281-288.
  • 7Barrena M N, Wright J D, Herzog T J. Targeted therapies in epithelial ovarian cancer [J]. J Oncol, 2010, 2010: 314-326.
  • 8Lage H, Denkert C. Resistance to chemotherapy in ovarian carcinoma [J]. Recent Results Cancer Res, 2007, 176 (3): 51-60.
  • 9American Cancer Society. Cancer Facts:Figures 2009[M]. Atlanta: American Cancer Society, 2009: 72.
  • 10Sabourin J C. Epithelial ovarian cancer dysplasia: At last a "precancerous" lesion of the ovary [J]. Ann Pathol, 2011, 31 (1) : 2.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部